Trials / Completed
CompletedNCT02505139
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
Using Circulating Tumor Cells to Diagnose and Predict Prognosis in Metastatic Nasopharyngeal Carcinoma Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 166 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A circulating tumor cell (CTC) count is an established prognostic factor in some malignancies such as metastatic breast cancer. However, the value of CTC in diagnosis and outcome prediction of metastatic nasopharyngeal carcinoma (mNPC) patients is not unknown. Through the observational prospective clinical trial, sensitivity, specificity, positive and negative predictive values of CTC in diagnosis of mNPC patients will be gained. Further, the value of CTC in outcome prediction of mNPC patients will be uncovered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | the number of circulating tumor cells |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-07-01
- Completion
- 2016-08-01
- First posted
- 2015-07-22
- Last updated
- 2016-08-29
Source: ClinicalTrials.gov record NCT02505139. Inclusion in this directory is not an endorsement.